Abstracts Selected for Presentation at 2013 Annual Meeting Program Committee of the American Society for Radiation Oncology
Author Name |
Abstract Title |
| Julie Bradley, M.D. | Pilot Study of Proton Therapy for Treatment of Regional Lymphatics in Breast Cancer Patients |
| Curtis Bryant, M.D. | Bladder‐Preservation Therapy for Small Cell Carcinoma of the Bladder |
| Richard Cassidy, M.D. | Function Preservation after Conservative Resection and Radiotherapy for Soft Tissue Sarcoma of the Distal Extremity as Evaluated by the Toronto Extremity Salvage Score (TESS) |
| Kaitlin Christopherson | Radiation Therapy for Sinonasal Undifferentiated Carcinoma |
| Kaitlin Christopherson | Factors Impacting Long‐term Local Control in Non‐Metastatic Medulloblastoma |
| Roi Dagan, M.D. | Initial Outcomes from the University of Florida Experience with Stereotactic Ablative Rasiotherapy (SABR) for Oligometastases |
| Rohan Deraniyagala, M.D. | Improving Patient Safety One Error at a Time: Implementing an Electronic Error Reporting System in a Radiation Oncology Clinic |
| Julie Greenwalt, M.D. | Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma |
| Julie Greenwalt, M.D. | Primary Radiation Therapy for Adolescent and Young Adult Patients with Nasopharyngeal Cancer |
| Randal Henderson, M.D., MBA | Early Gastrointestinal Toxicity Outcomes from a Prospective Trial of Accelerated Hypofractionation with Proton Therapy for Prostate Cancer |
| Tyler Hollen, M.D. | Squamous Cell Carcinoma of the Lip: A Retrospective Analysis of the University of Florida Experience |
| Michael Herman, M.D. | Evidence of Efficacy from Radiation Therapy following Surgery for Oral Cavity Squamous Cell Carcinoma |
| Adam Holtzman, M.D. | Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer following Cryosurgery or HIFU |
| Brad Hoppe, M.D., MPH | Phase II Study of Consolidative Involved‐Node Proton Therapy in Patients with Hodgkin Lymphoma: Early Outcomes |
| Brad Hoppe, M.D., MPH | Comparative Effectiveness Study of Proton Therapy versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient‐reported Outcomes |
| Daniel Indelicato, M.D. | Incidence and Dosimetric Parameters of Brainstem Toxicity Following Proton Therapy |
| Whoon Kil, M.D. | Patient‐reported Hip Symptoms Following Treatment with Proton Therapy for Prostate Cancer |
| Thomas Kole, | A Dosimetric Comparison of Hypofractionated Passively‐Scattered Proton Radiotherapy and Stereotactic Body Radiotherapy (SBRT) in the Definitive Treatment of Localized Prostate Cancer |
| Lisa McGee, M.D. | Pulmonary Toxicity Following Proton Therapy for Patients with Non‐Small Cell Lung Cancer |
| Nancy Mendenhall, M.D. | Five‐Year Outcomes of Proton Therapy in Localized Prostate Cancer on Three Prospective Trials for Low‐, Intermediate‐, and High‐Risk Prostate Cancer |
| Romaine Nichols, M.D. | Serum Testosterone Changes in Patients Treated with Radiotherapy Alone for Prostate Cancer on RTOG 9408 |
| Shayna Rich, M.D. | Offering and Enrolling Patients in Outcomes Tracking or Clinical Trials |
| Michael Scott, M.D. | Radiotherapy for Hemangiopericytoma |
| Tamara Smith | Grade 3 Genitourinary Toxicities in Men after Proton Therapy for Prostate Cancer |
| Emily Tanzler, M.D. | Meningiomas: A Retrospective Outcomes Analysis of the University of Florida Proton Institute Experience. |
| Noelle Williams, M.D. | Late Effects Following Radiotherapy for Childhood Low‐Grade Glioma |
| Ross Zeitlin | Fiducial Markers, Rectal Saline, and Rectal Balloons as Prostate Localization and Stabilization Strategies in Patients Receiving Proton Therapy |
